AST2818 in Advanced Non-Small Cell Lung Cancer With EGFR Mutations
Clinical trial NCT03127449 · TERMINATED
Trial details
- NCT number
- NCT03127449
- Sponsor
- Allist Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-01
- Primary completion
- 2021-05-12
- Enrollment
- 116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.